Study Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) When Administered Via Subcutaneous Auto-injector vs Intramuscular Injection Via Needle and Syringe in Healthy Post-menopausal Women
Clinical trial NCT02937766 · TERMINATED
Trial details
- NCT number
- NCT02937766
- Sponsor
- AMAG Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-07
- Primary completion
- 2017-01-06
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.